Sisram Medical Ltd. (HK:1696) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sisram Medical Ltd has announced the opening of a new direct office in Thailand, initiating operations with the injectable product Profhilo® after obtaining approval from the Thailand Food and Drug Administration. The company aims to enhance customer service, strengthen local market relationships, and increase brand awareness in the dynamic Southeast Asian economy. This strategic expansion is expected to drive long-term growth and shareholder returns by promoting a full portfolio in the wellness ecosystem.
For further insights into HK:1696 stock, check out TipRanks’ Stock Analysis page.